Cargando…
First‐in‐Human Single‐Ascending‐Dose, Multiple‐Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy
Painful diabetic peripheral neuropathy is characterized by burning, stabbing, or electric shock–type pain, which severely impacts day‐to‐day functioning and quality of life. Here, we report the results of 3 phase I studies with NRD135S.E1 (referred to as NRD.E1), a new, orally available chemical ent...
Autores principales: | Tiecke, Eva, Rainisio, Maurizio, Guentert, Theodor, Müller, Stephan, Hochman, Liat, Kaplan, Eli, Mangialaio, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541015/ https://www.ncbi.nlm.nih.gov/pubmed/35699261 http://dx.doi.org/10.1002/cpdd.1103 |
Ejemplares similares
-
NRD.E1, an innovative non‐opioid therapy for painful diabetic peripheral neuropathy—A randomized proof of concept study
por: Tiecke, Eva, et al.
Publicado: (2022) -
Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor
por: Jiao, Alan L., et al.
Publicado: (2019) -
NRDE2 negatively regulates exosome functions by inhibiting MTR4 recruitment and exosome interaction
por: Wang, Jianshu, et al.
Publicado: (2019) -
Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies
por: Desai, Amit, et al.
Publicado: (2020) -
Structural basis of Nrd1–Nab3 heterodimerization
por: Chaves-Arquero, Belén, et al.
Publicado: (2022)